[1]
I. Bulut and Z. Yegin Katran, “Reclassification of NSAID hypersensitivity according to the WAO 2025 guidelines: insights from a cohort of 527 patients”, Allergol Immunopathol, vol. 54, no. 1, pp. 166–171, Jan. 2026, doi: 10.15586/aei.v54i1.1579.